Maurizio D'Incalci

Head

IRCCS Humanitas Research Hospital

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Maurizio D'Incalci is the Head at IRCCS Humanitas Research Hospital in Italy. His research focuses on the molecular mechanisms of cancer treatment, particularly involving new therapeutic approaches such as Tumor Treating Fields and machine learning frameworks for ovarian cancer classification. His recent publications delve into immune evasion in high-grade serous ovarian carcinoma and the impact of various drug treatments on tumor responses.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

ITALY

View details

Fabio Grizzi

Head Histology Core

IRCCS Humanitas Research Hospital

ITALY

View details

Robert G. Maki

Professor, Member

UNITED STATES

View details

Salvatore Lorenzo Renne

Assistant Professor

Humanitas University

ITALY

View details

Ulf Dietrich Kahlert

Head/ Full professor

Otto-von-Guericke Universität Magdeburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maurizio D'Incalci

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics

Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB

HR-SC—an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib

Tumor Treating Fields enhance chemotherapy efficacy by increasing cellular drug uptake and retention in mesothelioma cells

Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study)

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields)

Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube.

Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging

Disruptions in antigen processing and presentation machinery on sarcoma

Mechanism of efficacy of trabectedin against myxoid liposarcoma entails detachment of the FUS-DDIT3 transcription factor from its DNA binding sites

Collaborators (10)

Roberta Sanfilippo

Domenico Mavilio

Sergio Marchini

Piergiuseppe Colombo

Paolo Zucali

Marina Meroni

Fabio Grizzi

Robert G. Maki

Salvatore Lorenzo Renne

Ulf Dietrich Kahlert

Make your next move.